Theragen Etex (Korea) Performance
| 066700 Stock | KRW 3,205 70.00 2.23% |
The entity has a beta of 0.12, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Theragen Etex's returns are expected to increase less than the market. However, during the bear market, the loss of holding Theragen Etex is expected to be smaller as well. At this point, Theragen Etex CoLtd has a negative expected return of -0.13%. Please make sure to validate Theragen Etex's mean deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if Theragen Etex CoLtd performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Theragen Etex CoLtd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
| Total Cashflows From Investing Activities | -2.9 B |
Theragen |
Theragen Etex Relative Risk vs. Return Landscape
If you would invest 351,500 in Theragen Etex CoLtd on September 14, 2024 and sell it today you would lose (31,000) from holding Theragen Etex CoLtd or give up 8.82% of portfolio value over 90 days. Theragen Etex CoLtd is generating negative expected returns and assumes 2.1735% volatility on return distribution over the 90 days horizon. Simply put, 19% of stocks are less volatile than Theragen, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Theragen Etex Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Theragen Etex's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Theragen Etex CoLtd, and traders can use it to determine the average amount a Theragen Etex's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0613
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 066700 |
Estimated Market Risk
| 2.17 actual daily | 19 81% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Theragen Etex is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Theragen Etex by adding Theragen Etex to a well-diversified portfolio.
Theragen Etex Fundamentals Growth
Theragen Stock prices reflect investors' perceptions of the future prospects and financial health of Theragen Etex, and Theragen Etex fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Theragen Stock performance.
| Return On Equity | 3.46 | |||
| Return On Asset | -0.0115 | |||
| Profit Margin | (0.06) % | |||
| Operating Margin | (0.05) % | |||
| Current Valuation | 298.28 B | |||
| Shares Outstanding | 30.48 M | |||
| Price To Earning | 65.80 X | |||
| Price To Sales | 0.77 X | |||
| Revenue | 166.57 B | |||
| EBITDA | (3.21 B) | |||
| Cash And Equivalents | 12.17 B | |||
| Cash Per Share | 380.87 X | |||
| Total Debt | 39.3 B | |||
| Debt To Equity | 0.12 % | |||
| Cash Flow From Operations | 4.01 B | |||
| Total Asset | 350.07 B | |||
| Retained Earnings | (21.23 B) | |||
| Current Asset | 85.2 B | |||
| Current Liabilities | 47.75 B | |||
About Theragen Etex Performance
By analyzing Theragen Etex's fundamental ratios, stakeholders can gain valuable insights into Theragen Etex's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Theragen Etex has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Theragen Etex has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products. ,Ltd. was founded in 1987 and is headquartered in Seoul, South Korea. THERAGEN ETEX is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about Theragen Etex CoLtd performance evaluation
Checking the ongoing alerts about Theragen Etex for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Theragen Etex CoLtd help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Theragen Etex CoLtd generated a negative expected return over the last 90 days | |
| The company reported the revenue of 166.57 B. Net Loss for the year was (11.38 B) with profit before overhead, payroll, taxes, and interest of 45.59 B. | |
| About 17.0% of the company shares are owned by insiders or employees |
- Analyzing Theragen Etex's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Theragen Etex's stock is overvalued or undervalued compared to its peers.
- Examining Theragen Etex's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Theragen Etex's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Theragen Etex's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Theragen Etex's stock. These opinions can provide insight into Theragen Etex's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Theragen Stock analysis
When running Theragen Etex's price analysis, check to measure Theragen Etex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theragen Etex is operating at the current time. Most of Theragen Etex's value examination focuses on studying past and present price action to predict the probability of Theragen Etex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theragen Etex's price. Additionally, you may evaluate how the addition of Theragen Etex to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |